JP2023529065A5 - - Google Patents

Info

Publication number
JP2023529065A5
JP2023529065A5 JP2022568723A JP2022568723A JP2023529065A5 JP 2023529065 A5 JP2023529065 A5 JP 2023529065A5 JP 2022568723 A JP2022568723 A JP 2022568723A JP 2022568723 A JP2022568723 A JP 2022568723A JP 2023529065 A5 JP2023529065 A5 JP 2023529065A5
Authority
JP
Japan
Prior art keywords
composition according
nanoparticles
hpv
immunogenic fragment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022568723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023529065A (ja
Filing date
Publication date
Priority claimed from EP20174156.8A external-priority patent/EP3909612A1/en
Application filed filed Critical
Publication of JP2023529065A publication Critical patent/JP2023529065A/ja
Publication of JP2023529065A5 publication Critical patent/JP2023529065A5/ja
Pending legal-status Critical Current

Links

JP2022568723A 2020-05-12 2021-05-12 Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物 Pending JP2023529065A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20174156.8A EP3909612A1 (en) 2020-05-12 2020-05-12 Composition of nanoparticles
EP20174156.8 2020-05-12
EP20196027.5 2020-09-14
EP20196027.5A EP3909614A1 (en) 2020-05-12 2020-09-14 Composition of nanoparticles as carrier for hpv-derived immunogenic fragments
PCT/EP2021/062748 WO2021229014A1 (en) 2020-05-12 2021-05-12 Composition of nanoparticles as carrier for hpv-derived immunogenic fragments

Publications (2)

Publication Number Publication Date
JP2023529065A JP2023529065A (ja) 2023-07-07
JP2023529065A5 true JP2023529065A5 (cg-RX-API-DMAC7.html) 2024-05-22

Family

ID=70682623

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022568723A Pending JP2023529065A (ja) 2020-05-12 2021-05-12 Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物
JP2022568554A Pending JP2023524874A (ja) 2020-05-12 2021-05-12 ナノ粒子の組成物
JP2022568724A Pending JP2023529066A (ja) 2020-05-12 2021-05-12 アジュバント／抗原の担体系としてのナノ粒子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022568554A Pending JP2023524874A (ja) 2020-05-12 2021-05-12 ナノ粒子の組成物
JP2022568724A Pending JP2023529066A (ja) 2020-05-12 2021-05-12 アジュバント／抗原の担体系としてのナノ粒子

Country Status (4)

Country Link
US (4) US20240197909A1 (cg-RX-API-DMAC7.html)
EP (6) EP3909612A1 (cg-RX-API-DMAC7.html)
JP (3) JP2023529065A (cg-RX-API-DMAC7.html)
WO (3) WO2021229015A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3909612A1 (en) * 2020-05-12 2021-11-17 Life Science Inkubator Betriebs GmbH & Co. KG Composition of nanoparticles
CN113274492B (zh) * 2021-05-21 2022-06-17 大连理工大学 一种基于羟基氧化铝纳米羧基改性的复合疫苗佐剂的制备方法
EP4547258A4 (en) * 2022-06-28 2026-08-05 Transcode Therapeutics Inc Matrix-Directed Rig-I Agonitor Nanoparticles and Precursor Compositions and Their Uses in Cancer Therapy
EP4551242A4 (en) * 2022-07-08 2026-06-24 Mark C Poznansky VACCINE CONTAINING A PROTEIN IMMUNE ADJUVANT
EP4673170A1 (en) * 2023-03-02 2026-01-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts A therapeutic hpv vaccine based on validated target epitopes
CN120857941A (zh) * 2023-03-02 2025-10-28 德国癌症研究公共权益基金会 经验证的hpv16衍生的刺激肽
EP4673166A1 (en) * 2023-03-02 2026-01-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Therapeutic hpv vaccines based on validated target epitopes

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616133A1 (de) 1985-09-25 1987-11-19 Merck Patent Gmbh Kugelfoermige sio(pfeil abwaerts)2(pfeil abwaerts)-partikel
US6419931B1 (en) * 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
ES2148259T3 (es) 1993-09-22 2000-10-16 Hoechst Ag Pro-profarmacos, su produccion y uso.
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
DE19912502A1 (de) * 1999-03-19 2000-09-21 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung
IL148844A0 (en) 1999-09-27 2002-09-12 Coley Pharm Group Inc Methods related to immunostimulatory nucleic acid-induced interferon
KR100919266B1 (ko) * 2000-06-26 2009-09-30 엔벤타 바이오파마슈티컬스 코포레이션 인간 파필로마 바이러스 치료법
DE102004011110A1 (de) 2004-03-08 2005-09-22 Merck Patent Gmbh Verfahren zur Herstellung monodisperser SiO2-Partikel
US20060088599A1 (en) * 2004-08-02 2006-04-27 Prasad Paras N Amino functionalized ORMOSIL nanoparticles as delivery vehicles
ES2625905T3 (es) 2004-10-01 2017-07-20 Midatech Ltd. Nanopartículas que comprenden antígenos y adyuvantes capaces de estimular linfocitos T cooperadores
WO2006063252A2 (en) 2004-12-09 2006-06-15 Alnylam Pharmaceuticals, Inc. Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
CN101160048A (zh) * 2004-12-30 2008-04-09 哈达斯特医学研究服务与开发有限公司 形成非析出性持续抗微生物聚合组合物的抗微生物纳米颗粒添加剂
WO2007031734A1 (en) 2005-09-14 2007-03-22 Ucb Pharma S.A. Comb polymers
EP1764107A1 (en) 2005-09-14 2007-03-21 Gunther Hartmann Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides
JP2010500011A (ja) 2006-08-08 2010-01-07 ガンサー ハートマン ５’リン酸オリゴヌクレオチドの構造および使用
FR2908305B1 (fr) 2006-11-10 2009-02-27 Oreal Procede de deformation permanente des fibres keratiniques comprenant une etape d'application d'une composition de rincage intermediaire comprenant un sel de cation metallique monovalent ou un sel d'ammonium et un acide organique
JP5448369B2 (ja) * 2008-05-15 2014-03-19 古河電気工業株式会社 粒子表面にアミノ基を有するシリカ粒子の製造方法、粒子表面にアミノ基を有するシリカ粒子、及びそれを用いた複合粒子
DK2518150T3 (en) 2008-05-21 2015-12-07 Univ Bonn 5'Trip phosphate triphosphate oligonucleotide and uses thereof
US9738680B2 (en) 2008-05-21 2017-08-22 Rheinische Friedrich-Wilhelms-Universität Bonn 5′ triphosphate oligonucleotide with blunt end and uses thereof
DE102008033175A1 (de) 2008-07-15 2010-01-21 Merck Patent Gmbh Siliciumdioxid-Nanopartikel und deren Verwendung zur Vakzinierung
EP3263707A1 (en) 2009-03-17 2018-01-03 Rheinische Friedrich-Wilhelms-Universität Bonn Tlr8 ligand and uses thereof
ES2366841B1 (es) * 2010-04-06 2013-01-24 Consejo Superior De Investigaciones Cientificas (Csic) (45%) Nanoparticulas de silice para difusion intracelular de agentes bioactivos poco solubles
CN103002922B (zh) 2010-06-10 2015-11-25 Mida科技有限公司 携带肽的纳米颗粒
DE102011018499A1 (de) * 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
BR112014005362A2 (pt) 2011-09-07 2017-06-13 Immunotope Inc vacinas de tumor com nanopartículas
JP6077544B2 (ja) 2011-09-07 2017-02-08 ミダテック リミテッド ナノ粒子−ペプチド組成物
EP2883550A1 (en) 2013-12-12 2015-06-17 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Novel promiscuous HPV16-derived T helper epitopes for immunotherapy
MA39909B1 (fr) 2014-04-25 2019-05-31 Pf Medicament Conjugué anticorps de l'igf-1r-médicament et son utilisation pour le traitement du cancer
WO2016013751A1 (ko) * 2014-07-22 2016-01-28 주식회사 레모넥스 생리활성 물질 또는 단백질 전달용 조성물 및 이의 용도
US20160090603A1 (en) * 2014-09-30 2016-03-31 Sandia Corporation Delivery platforms for the domestication of algae and plants
EP3370741B1 (en) * 2015-11-04 2025-10-08 The Trustees of the University of Pennsylvania Methods and compositions for gene editing in hematopoietic stem cells
PT3319587T (pt) * 2015-11-17 2019-11-20 Bioncotech Therapeutics S L Nova composição farmacêutica que compreende partículas compreendendo um complexo de um polirribonuleótido de cadeia dupla e uma polialquilenoimina
EP3471778A4 (en) * 2016-06-20 2020-02-19 The Regents of The University of Michigan COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES
EP3535284B1 (en) 2016-11-07 2021-04-21 The United States of America as represented by The Secretary Department of Health and Human Services Development of agonist epitopes of the human papillomavirus
WO2019028387A1 (en) * 2017-08-03 2019-02-07 Rita Elena Serda LIPOSOMAL COATED NANOPARTICLES FOR IMMUNOTHERAPY APPLICATIONS
GB201718817D0 (en) * 2017-11-14 2017-12-27 N4 Pharma Uk Ltd Particulate material production process
US20210196838A1 (en) * 2018-08-24 2021-07-01 Mirexus Biotechnologies Inc. Compounds and compositions for potentiation of tlr agonists
EP3909612A1 (en) * 2020-05-12 2021-11-17 Life Science Inkubator Betriebs GmbH & Co. KG Composition of nanoparticles

Similar Documents

Publication Publication Date Title
JP2023529066A5 (cg-RX-API-DMAC7.html)
JP2023524874A5 (cg-RX-API-DMAC7.html)
CN114366809B (zh) 一种铝纳米晶递送系统及其结合疫苗抗原分子自组装颗粒佐剂疫苗
CN103372217B (zh) 聚合物纳米载体制剂及其制备方法和应用
CN108078958B (zh) 一种抗肿瘤多肽纳米药物及其制备方法和应用
CN103690961B (zh) 一种智能两亲性聚合物纳米胶束及其制备方法和应用
JP2019537424A5 (cg-RX-API-DMAC7.html)
JP2012532185A5 (cg-RX-API-DMAC7.html)
CN106008716B (zh) 呼吸道合胞病毒抗原组合物和方法
CN111658780A (zh) 一种基于阴离子聚合物及其衍生物制备的疫苗载体
ES2246695A1 (es) Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
Dong et al. A visible fluorescent nanovaccine based on functional genipin crosslinked ovalbumin protein nanoparticles
JP2016510813A (ja) ワクチン接種用組成物
CN110139826A (zh) 具有负的表面电荷的微粒和纳米颗粒
US20230310621A1 (en) Complexes for the delivery of proteinaceous agents
JP2023529066A (ja) アジュバント／抗原の担体系としてのナノ粒子
JP2023529839A5 (cg-RX-API-DMAC7.html)
CN102397266A (zh) 纳米颗粒的制备方法及用该方法制备的纳米颗粒
CN115501322A (zh) 用于肿瘤免疫治疗的多肽药物偶联物、载药系统、药物组合系统及应用
Zhao et al. Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus
CN114615986B (zh) 具备cGAS-STING通路激活功能的纳米颗粒及其制备方法和应用
JP2004521911A (ja) 投薬方式
Hasnain et al. Carbon nanotubes in vaccine delivery
CN110694057A (zh) 一种可控捕获/释放抗原的纳米复合胶束癌症疫苗的制备方法
JP2020530453A5 (cg-RX-API-DMAC7.html)